Beranda › Disfungsi Ventrikel Kiri › Massachusetts › Boston
Uji klinis Disfungsi Ventrikel Kiri di Boston, MA
3 studi untuk Disfungsi Ventrikel Kiri mencari peserta di lokasi sekitar Boston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Menerima pesertaFase 2/3
- Boston Children's Hospital ( Site 0035), Boston
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Menerima pesertaFase 3
- Boston Children's Hospital - Main Campus - Cardiology, Boston
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Menerima pesertaFase 3
- Boston Children's Hospital - Main Campus - Cardiology, Boston
Uji klinis Disfungsi Ventrikel Kiri di kota lain
- New York City, NY4 studi
- Cleveland, OH4 studi
- Atlanta, GA3 studi
- The Bronx, NY3 studi
- St. Louis, MO3 studi
- Aurora, CO3 studi
- Pittsburgh, PA3 studi
- Dallas, TX3 studi
- Houston, TX3 studi
- Philadelphia, PA3 studi
- Cincinnati, OH3 studi
- Ann Arbor, MI3 studi
Studi lain di Boston
- Kanker Payudara111 studi
- Kanker Paru Non-Sel Kecil89 studi
- Kanker (semua jenis)86 studi
- Kanker Kolorektal63 studi
- Kanker Metastatik63 studi
- Kanker Paru62 studi
- Kanker Ovarium61 studi
- Kanker Prostat60 studi
- Depresi52 studi
- Kanker Endometrium50 studi
- Leukemia Mieloid Akut44 studi
- Kanker Pankreas44 studi
Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.